Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Average Rating of “Moderate Buy” by Brokerages
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average twelve-month price objective […]
More Stories
QRG Capital Management Inc. Sells 994 Shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR)
QRG Capital Management Inc. cut its position in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by QRG Capital Management Inc.
QRG Capital Management Inc. decreased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 1.4% during...
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Cornerstone Wealth Management LLC
Cornerstone Wealth Management LLC cut its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 21.1% in the...
Kingswood Wealth Advisors LLC Acquires 39 Shares of Booking Holdings Inc. (NASDAQ:BKNG)
Kingswood Wealth Advisors LLC boosted its holdings in shares of Booking Holdings Inc. (NASDAQ:BKNG – Free Report) by 27.3% during...
QRG Capital Management Inc. Trims Position in Sysco Corporation (NYSE:SYY)
QRG Capital Management Inc. trimmed its holdings in shares of Sysco Corporation (NYSE:SYY – Free Report) by 15.2% during the...
Cornerstone Wealth Management LLC Trims Stock Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)
Cornerstone Wealth Management LLC lowered its holdings in T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) by 36.7% in the first...